Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.540
+0.035 (1.00%)
At close: Mar 6, 2026, 4:00 PM EST
3.636
+0.096 (2.70%)
After-hours: Mar 6, 2026, 7:59 PM EST
Altimmune Employees
Altimmune had 59 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
59
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$695
Profits / Employee
-$1,493,102
Market Cap
460.45M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| REGENXBIO | 353 |
| Lyell Immunopharma | 300 |
| Rocket Pharmaceuticals | 202 |
| Entrada Therapeutics | 152 |
| Century Therapeutics | 150 |
| Kyverna Therapeutics | 129 |
| Lineage Cell Therapeutics | 77 |
ALT News
- 1 day ago - Altimmune, Inc. (ALT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Altimmune Announces Fourth Quarter and Full-year 2025 Financial Results and Business Updates - GlobeNewsWire
- 5 days ago - Altimmune to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 9 days ago - Altimmune to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 - GlobeNewsWire
- 4 weeks ago - Obesity stocks slump on Novo's underwhelming 2026 sales forecast - Reuters
- 5 weeks ago - Altimmune Announces Closing of $75 Million Registered Direct Offering of Common Stock - GlobeNewsWire
- 5 weeks ago - Altimmune (ALT) Shares Slide On $75 Million Stock Offering - Benzinga
- 5 weeks ago - Altimmune Announces Pricing of $75 Million Registered Direct Offering of Common Stock - GlobeNewsWire